Literature DB >> 34357471

Dexmedetomidine Restores Autophagic Flux, Modulates Associated microRNAs and the Cholinergic Anti-inflammatory Pathway upon LPS-Treatment in Rats.

Widuri Kho1, Clarissa von Haefen2, Nadine Paeschke1, Fatme Nasser1, Stefanie Endesfelder3, Marco Sifringer1, Adrián González-López1,4, Nadine Lanzke1, Claudia D Spies1.   

Abstract

Infections and perioperative stress can lead to neuroinflammation, which in turn is linked to cognitive impairments such as postoperative delirium or postoperative cognitive dysfunctions. The α2-adrenoceptor agonist dexmedetomidine (DEX) prevents cognitive impairments and has organo-protective and anti-inflammatory properties. Macroautophagy (autophagy) regulates many biological processes, but its role in DEX-mediated anti-inflammation and the underlying mechanism of DEX remains largely unclear. We were interested how a pretreatment with DEX protects against lipopolysaccharide (LPS)-induced inflammation in adult male Wistar rats. We used Western blot and activity assays to study how DEX modulated autophagy- and apoptosis-associated proteins as well as molecules of the cholinergic anti-inflammatory pathway, and qPCR to analyse the expression of autophagy and inflammation-associated microRNAs (miRNA) in the spleen, cortex and hippocampus at different time points (6 h, 24 h, 7 d). We showed that a DEX pretreatment prevents LPS-induced impairments in autophagic flux and attenuates the LPS-induced increase in the apoptosis-associated protein cleaved poly(ADP-ribose)-polymerase (PARP) in the spleen. Both, DEX and LPS altered miRNA expression and molecules of the cholinergic anti-inflammatory pathway in the spleen and brain. While only a certain set of miRNAs was up- and/or downregulated by LPS in each tissue, which was prevented or attenuated by a DEX pretreatment in the spleen and hippocampus, all miRNAs were up- and/or downregulated by DEX itself - independent of whether or not they were altered by LPS. Our results indicate that the organo-protective effect of DEX may be mediated by autophagy, possibly by acting on associated miRNAs, and the cholinergic anti-inflammatory pathway. Preventive effects of DEX on LPS-induced inflammation. DEX restores the LPS-induced impairments in autophagic flux, attenuates PARP cleavage and alters molecules of the cholinergic system in the spleen. Furthermore, DEX alters and prevents LPS-induced miRNA expression changes in the spleen and brain along with LPS.
© 2021. The Author(s).

Entities:  

Keywords:  Autophagy; Brain; Cholinergic anti-inflammatory pathway; Dexmedetomidine; Spleen; microRNA

Year:  2021        PMID: 34357471     DOI: 10.1007/s11481-021-10003-w

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  55 in total

Review 1.  Dexmedetomidine effects in different experimental sepsis in vivo models.

Authors:  Ioannis Dardalas; Eleni Stamoula; Panagiotis Rigopoulos; Faye Malliou; Georgia Tsaousi; Zoi Aidoni; Vasileios Grosomanidis; Antonios Milonas; Georgios Papazisis; Dimitrios Kouvelas; Chryssa Pourzitaki
Journal:  Eur J Pharmacol       Date:  2019-05-17       Impact factor: 4.432

Review 2.  How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy.

Authors:  Yuchen Feng; Zhiyuan Yao; Daniel J Klionsky
Journal:  Trends Cell Biol       Date:  2015-03-08       Impact factor: 20.808

3.  Dexmedetomidine reduces inflammation in traumatic brain injury by regulating the inflammatory responses of macrophages and splenocytes.

Authors:  Mengyao Ding; Ying Chen; Hengfei Luan; Xiaobao Zhang; Zhibin Zhao; Yong Wu
Journal:  Exp Ther Med       Date:  2019-07-18       Impact factor: 2.447

4.  Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons.

Authors:  M Alkondon; E F Pereira; W S Cortes; A Maelicke; E X Albuquerque
Journal:  Eur J Neurosci       Date:  1997-12       Impact factor: 3.386

Review 5.  miR-34a in Neurophysiology and Neuropathology.

Authors:  Christelle En Lin Chua; Bor Luen Tang
Journal:  J Mol Neurosci       Date:  2018-11-28       Impact factor: 3.444

6.  The impact of microRNAs on protein output.

Authors:  Daehyun Baek; Judit Villén; Chanseok Shin; Fernando D Camargo; Steven P Gygi; David P Bartel
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

Review 7.  Autophagy in infection, inflammation and immunity.

Authors:  Vojo Deretic; Tatsuya Saitoh; Shizuo Akira
Journal:  Nat Rev Immunol       Date:  2013-10       Impact factor: 53.106

8.  Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers.

Authors:  Ingrid Balcells; Susanna Cirera; Peter K Busk
Journal:  BMC Biotechnol       Date:  2011-06-25       Impact factor: 2.563

9.  Neuroprotective effects of dexmedetomidine against hyperoxia-induced injury in the developing rat brain.

Authors:  Stefanie Endesfelder; Hanan Makki; Clarissa von Haefen; Claudia D Spies; Christoph Bührer; Marco Sifringer
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

10.  A tool for design of primers for microRNA-specific quantitative RT-qPCR.

Authors:  Peter K Busk
Journal:  BMC Bioinformatics       Date:  2014-01-28       Impact factor: 3.169

View more
  1 in total

Review 1.  The Role of miRNAs in Dexmedetomidine's Neuroprotective Effects against Brain Disorders.

Authors:  Codrin-Constantin Burlacu; Maria-Adriana Neag; Andrei-Otto Mitre; Alexandru-Constantin Sirbu; Andrei-Vlad Badulescu; Anca-Dana Buzoianu
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.